Case File
efta-efta01935202DOJ Data Set 10CorrespondenceEFTA Document EFTA01935202
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01935202
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey EpsteinUeevacationagmail.comj
From:
Sent
Sun 3/2/2014 3:53:28 PM
Subject Joe Thakuria
Hi Richard, my study is still awaiting irb approval at mgh. Once that goes through, there'll be a
consent form for Jeffrey to review and sign and then I can forward the invoice from Illumina for
the rapid turn-around-time whole genome.
Once we have his data and go through the analyses Illumina provides, I can discuss with him any
extra value from using additional tools for analyses.
The irb approval process will take 3-5 weeks in the best case scenario. As a physician, I could just
order it for him from Illumina but Jeffrey and I agreed the research route made the most sense.
For one, ordering a whole genome on a (presumably) healthy patient is not currently indicated.
Doing this as a patient (at least at mgh) would also entail creating a medical record of the
encounter and the results. Our plan is to keep this data private - at least until he's had a chance to
review with me. So, for this reason, we also agreed to go the "research study" route with his
genome.
I've discussed doing Jeffrey's genome through my mgh study with george church and he's fine
with it. I'll coordinate getting JE's samples from the pgp and moving all of it, or a portion
(aliquots of the dna and cell lines) to the new study (again, after the mgh study is formally
approved - that's the bottleneck now).
with Jeffrey not on the cc, please pass the info above on to him. Let me know if he has
any questions. I can clarify anything by email or phone.
Maybe there was a misunderstanding when I mentioned the 'rapid turnaround time' offering from
illumina? This just means illumina's role - the sequencing of the sample - is expedited. There is no
way, unfortunately, to expedite the MGH IRB process for approving human research studies. (A
lot of us wish there was!)
Joe Thakuria
Joseph V. Thakuria, MD, MMSc
Medical Genetics and Metabolism Attending Physician
Director, MGH Stickler Syndrome Program
Harvard Catalyst CRC Protocol Review Committee
Massachusetts General Hospital
185 Cambridge St., Rm. 2222
EFTA_R1_00389812
EFTA01935202
Related Documents (6)
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA02059593
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01800346
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA02099168
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01867203
0p
Dept. of JusticeAug 22, 2017
15 July 7 2016 - July 17 2016 working progress_Redacted.pdf
Kristen M. Simkins From: Sent: To: Cc: Subject: Irons, Janet < Tuesday, July 12, 2016 10:47 AM Richard C. Smith Hello Warden Smith, mother is anxious to hear the results of your inquiry into her daughter's health. I'd be grateful if you could email or call me at your earliest convenience. I'm free today after 2 p.m. Alternatively, we could meet after the Prison Board of Inspectors Meeting this coming Thursday. Best wishes, Janet Irons 1 Kristen M. Simkins From: Sent:
1196p
DOJ Data Set 9OtherUnknown
From: Jeffrey Epstein <[email protected]>
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.